New Approaches to Management of Multiple Myeloma

Opinion statement Multiple myeloma is still an incurable disease with pattern of regression and remission followed by multiple relapses raising from the residual myeloma cells surviving even in the patients who achieve complete clinical response to treatment. New antimyeloma drugs such as thalidomid...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Current treatment options in oncology 2014-06, Vol.15 (2), p.157-170
Hauptverfasser:	Genadieva-Stavric, Sonja, Cavallo, Federica, Palumbo, Antonio
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Age Factors Aged Antibodies, Monoclonal - therapeutic use Antineoplastic Agents - classification Antineoplastic Agents - therapeutic use Boron Compounds - therapeutic use Boronic Acids - therapeutic use Bortezomib Depsipeptides - therapeutic use Frail Elderly Glycine - analogs & derivatives Glycine - therapeutic use Humans Leukemia (JP Dutcher Medicine Medicine & Public Health Middle Aged Multiple Myeloma - therapy Oligopeptides - therapeutic use Oncology Phosphorylcholine - analogs & derivatives Phosphorylcholine - therapeutic use Proteasome Inhibitors - therapeutic use Pyrazines - therapeutic use Quality of Life Recurrence Section Editor Thalidomide - analogs & derivatives Thalidomide - therapeutic use Treatment Outcome
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!